Atlas Trials

MultiVir, Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch MultiVir, Inc.

RecordFirmDate
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer (NCT02842125)MultiVir, Inc.2018-11-20
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. (NCT03544723)MultiVir, Inc.2018-10-01

Track MultiVir, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.